ImmunoScape is currently collaborating with Arcturus Therapeutics which began human trials of potential COVID-19 vaccine yesterday   By Monika Ghosh   Singapore-based biotech startup ImmunoScape announced in a press release today that it has raised US$11 million (SG$14.8 million) in an equity...